Determine best application of new targeted therapies in patients with early stage and metastatic disease

Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer

Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.

Be familiar with germ-line genetic testing options for hereditary breast cancer, including advantages and disadvantages of extended panel testing

Evaluate local therapy options for operable breast cancer depending on stage, and the use of neoadjuvant therapy

Identify evidence-based recommendations for decreasing symptoms and improving quantity and/or quality of life in survivors